Depo-medrol and Vaginal discharge - a phase IV clinical study of FDA data

Summary:

Vaginal discharge is found among people who take Depo-medrol, especially for people who are 50-59 old.

The phase IV clinical study analyzes which people take Depo-medrol and have Vaginal discharge. It is created by eHealthMe based on reports of 5,244 people who have side effects when taking Depo-medrol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

5,244 people reported to have side effects when taking Depo-medrol.
Among them, 12 people (0.23%) have Vaginal discharge.

What is Depo-medrol?

Depo-medrol has active ingredients of methylprednisolone acetate. It is often used in birth control. eHealthMe is studying from 5,329 Depo-medrol users for its effectiveness, alternative drugs and more.

What is Vaginal discharge?

Vaginal discharge is found to be associated with 1,631 drugs and 1,104 conditions by eHealthMe.

Number of Depo-medrol and Vaginal discharge reports submitted per year:

Could Depo-medrol cause Vaginal discharge?

Age of people who have Vaginal discharge when taking Depo-medrol *:

Common drugs people take besides Depo-medrol *:

Common side effects people have besides Vaginal discharge *:

Weight Increased: 10 people, 83.33%
Hepatic Lesion: 10 people, 83.33%
Fractured Sacrum: 10 people, 83.33%
Gastric Polyps (abnormal growth of stomach tissue projecting from a mucous membrane): 10 people, 83.33%
Gastritis (inflammation of stomach): 10 people, 83.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 83.33%
Haematochezia (passage of stools containing blood): 10 people, 83.33%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 10 people, 83.33%
Head Injury: 10 people, 83.33%
Hepatic Cyst: 10 people, 83.33%

Common conditions people have *:

Metastases To Bone (cancer spreads to bone): 10 people, 83.33%
Breast Cancer Metastatic: 2 people, 16.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Depo-medrol and have Vaginal discharge?

Check whether Vaginal discharge is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Vaginal discharge and when was it recovered:

Vaginal discharge in Depo-medrol

Expand to all the drugs that have ingredients of methylprednisolone acetate:

Vaginal discharge and drugs with ingredients of methylprednisolone acetate

Alternative drugs to, pros and cons of Depo-medrol:

Depo-medrol (5,329 reports)

Common Depo-medrol side effects:

Browse all side effects of Depo-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Vaginal discharge treatments and more:

Vaginal discharge (11,878 reports)

COVID vaccines that are related to Vaginal discharge:

Common drugs associated with Vaginal discharge:

All the drugs that are associated with Vaginal discharge:

Vaginal discharge (1,631 drugs)

Common conditions associated with Vaginal discharge:

Birth control: 2,509 reports
Rheumatoid arthritis: 240 reports
Crohn's disease: 201 reports
Multiple sclerosis: 170 reports
Pain: 160 reports

All the conditions that are associated with Vaginal discharge:

Vaginal discharge (1,104 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone acetate (the active ingredients of Depo-medrol) and Depo-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.